paracetamol "fresenius kabi" 10 mg/ml infusionsvæske, opløsning
fresenius kabi ab - paracetamol - infusionsvæske, opløsning - 10 mg/ml
phenergan 25 mg filmovertrukne tabletter
opella healthcare france sas - promethazinhydrochlorid - filmovertrukne tabletter - 25 mg
plasmalyte infusionsvæske, opløsning
baxter a/s - kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid, natriumgluconat - infusionsvæske, opløsning
rapifen 0,5 mg/ml injektionsvæske, opløsning
piramal critical care b.v. - alfentanilhydrochlorid - injektionsvæske, opløsning - 0,5 mg/ml
vermox 100 mg tabletter
mcneil denmark aps - mebendazol - tabletter - 100 mg
empressin 40 ie/2 ml koncentrat til infusionsvæske, opløsning
orpha devel handels- und vertr. - argipressin - koncentrat til infusionsvæske, opløsning - 40 ie/2 ml
suxamethonium chloride dihydrate "ethypharm" 50 mg/ml injektions-/infusionsvæske, opløsning
ethypharm - suxamethoniumchlorid (vandfrit) - injektions-/infusionsvæske, opløsning - 50 mg/ml
menquadfi
sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningitis, meningokok - vacciner - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.
paracetamol "baxter" 10 mg/ml infusionsvæske, opløsning
baxter holding b.v. - paracetamol - infusionsvæske, opløsning - 10 mg/ml
phenergan 25 mg filmovertrukne tabletter
2care4 aps - promethazinhydrochlorid - filmovertrukne tabletter - 25 mg